Brief: Bolt Biotherapeutics Inc - QTRLY Loss Per Share $0.61

Bolt Biotherapeutics

10/08/2022 22:33

Bolt Biotherapeutics Inc  BOLT.O :
    * BOLT BIOTHERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * QTRLY LOSS PER SHARE $0.61
    * CASH BALANCE OF $223.6 MILLION ANTICIPATED TO FUND KEY
MILESTONES THROUGH 2025
    * Q2 EARNINGS PER SHARE VIEW $-0.68 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX8fYzG7 
Further company coverage:  BOLT.O